News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Busier brain regions can become epicenters for MS atrophy

noviembre 13, 2026

Network-based measures could be used to explain future atrophy progression in individual patients.
Learn more

Exposure to workplace petroleum-based lubricants linked to MS risk

noviembre 12, 2026

The link was stronger among smokers and people who lack a gene associated with lower MS risk.
Learn more

Ofatumumab and siponimod found to be comparable to fingolimod in children

octubre 30, 2026

New study finds treatments were superior to interferon beta 1a in suppressing relapses.
Learn more

Treatment study suggests encouraging safety profile

octubre 28, 2026

Early findings and clinical outcomes support continued evaluation of azer-cel in progressive MS.
Learn more

New data suggests oral fenebrutin effective in relapsing, progressive MS

octubre 27, 2026

Ocrevus shown to provide consistent efficacy across a broad MS patient population.
Learn more

Participants sought for MS progression survey

septiembre 25, 2026

Findings will help inform future MS education and care conversations.
Learn more

Researchers discover Epstein-Barr Virus, MS attacks link

septiembre 17, 2026

The findings help explain how a common virus and genetic risk may work together to trigger relapses.
Learn more

Early MS treatments differ most in relapses, MRI lesions

septiembre 14, 2026

However, researchers found no differences between treatment groups in disability score changes at two years
Learn more

Researchers seek participants for quality of life study

septiembre 03, 2026

Worcester State University researchers are conducting interviews regarding social and leisure participation.
Learn more

Busier brain regions can become epicenters for MS atrophy

noviembre 13, 2026

Network-based measures could be used to explain future atrophy progression in individual patients.
Learn more

Exposure to workplace petroleum-based lubricants linked to MS risk

noviembre 12, 2026

The link was stronger among smokers and people who lack a gene associated with lower MS risk.
Learn more

Ofatumumab and siponimod found to be comparable to fingolimod in children

octubre 30, 2026

New study finds treatments were superior to interferon beta 1a in suppressing relapses.
Learn more

Treatment study suggests encouraging safety profile

octubre 28, 2026

Early findings and clinical outcomes support continued evaluation of azer-cel in progressive MS.
Learn more

New data suggests oral fenebrutin effective in relapsing, progressive MS

octubre 27, 2026

Ocrevus shown to provide consistent efficacy across a broad MS patient population.
Learn more

Participants sought for MS progression survey

septiembre 25, 2026

Findings will help inform future MS education and care conversations.
Learn more

Researchers discover Epstein-Barr Virus, MS attacks link

septiembre 17, 2026

The findings help explain how a common virus and genetic risk may work together to trigger relapses.
Learn more

Early MS treatments differ most in relapses, MRI lesions

septiembre 14, 2026

However, researchers found no differences between treatment groups in disability score changes at two years
Learn more

Researchers seek participants for quality of life study

septiembre 03, 2026

Worcester State University researchers are conducting interviews regarding social and leisure participation.
Learn more

Study: MS affects daily life far beyond its physical symptoms

junio 30, 2026

Findings show disease can have a substantial effect on key aspects of life including education, financial resources, social life, and work.
Learn more

Study suggests MS prevalence linked to living longer

junio 17, 2026

New study reveals different drivers behind rising numbers of MS, Parkinson’s, and motor neuron disease.
Learn more

PET imaging reveals synaptic loss in MS

junio 08, 2026

If validated in larger studies, imaging approach could be integrated into clinical practice and drug development.
Learn more

Researchers seeking participants for fatigue study

junio 03, 2026

Program will be conducted remotely.
Learn more

New study puts focus on differing MS research models

mayo 20, 2026

Research points to specific scenarios in which one model is better suited, depending on which aspect of MS is under investigation.
Learn more

FDA approves Ocrevus for relapsing-remitting MS in pediatric patients

mayo 12, 2026

The safety profile in pediatric patients was consistent with that observed in adult patients.
Learn more

Researchers seek participants for educational videos survey

mayo 07, 2026

The survey is being conducted collaboratively through MS Focus: the Multiple Sclerosis Foundation, University of Florida, and Conserve & Conquer.
Learn more

Scientists discover how multiple sclerosis kills neurons

abril 09, 2026

Inflammation caused by the disease damages DNA in neurons that are essential to higher thinking.
Learn more

Findings suggest mono linked to increased risk of MS

abril 07, 2026

People with a history of infectious mononucleosis were more likely to develop MS than people without it.
Learn more


Show More News